Effects of the ligand on the biological behavior of chromium complexes: their therapeutic possibilities as selective carriers
Anghileri, L.J.
Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 4(2): 169-174
1971
ISSN/ISBN: 0020-9392 PMID: 5550410 Document Number: 32892
Document emailed within 1 workday
Related Documents
Seeling, W.; Dölp, R.; Ahnefeld, F.W.; Dick, W. 1975: Studies on the behavior of chromium in serum and urine in polytraumatized patients as well as on the chromium concentration of various infusion solutions Infusionstherapie und Klinische Ernahrung 2(2): 144-150Seeling, W.; Dölp, R.; Ahnefeld, F.W.; Dick, W. 1975: Studies on the behavior of chromium in serum and urine in polytraumatized patients as well as on the chromium concentration of various infusion solutions Infusionstherapie und Klinische Ernahrung 2(2): 144-150
Nissen, G. 1978: Therapeutic possibilities in child behavior disorders Die Medizinische Welt 29(35): 1358-1361
Li, J.-m.; Wang, W.-q.; Ma, J.-y. 2014: Comparison of the clinical effects of selective laser melting deposition basal crowns and cobalt chromium alloy base crowns Shanghai Kou Qiang Yi Xue 23(3): 350-353
Strander, H. 1981: Interferon - effects and therapeutic possibilities Nordisk Medicin 96(3): 82-83
Sapach, V.K. 1990: The similarity of the biological effects from the parenteral administration of ascarid antigenic complexes and Salmonella typhi endotoxins Meditsinskaia Parazitologiia i Parazitarnye Bolezni 3: 33-35
Dauge, V.; Derrien, M.; Durieux, C.; Noble, F.; Corringer, P.J.; Roques, B.P. 1992: Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents Therapie 47(6): 531-539
Madalinski, K.; Burczynska, B.; Heermann, K.H.; Uy, A.; Gerlich, W.H. 1991: Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus Clinical and Experimental Immunology 84(3): 493-500
Kapusta, M.; Dusek, J. 2003: Therapeutic and toxicologic aspects of biological effects of Saint John's wort (Hypericum perforatum L.) Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 52(1): 20-28
Akhrem, A.A.; Lando, D.I. 1981: Effect of selectively reacting ligands on the helix-coil transition of DNA. III. Calculation of the melting curves of DNA-ligand complexes Molekuliarnaia Biologiia 15(5): 1083-1092
Lozak, A.; Sołtyk, K.; Ostapczuk, P.; Fijałek, Z. 2004: Determination of chromium, selenium, and molybdenum in a therapeutic diet Die Pharmazie 59(11): 824-827
Gupta, H.; Tandon, B.N. 1988: Detection of HBsAg in circulating immune complexes in asymptomatic carriers & various hepatic disorders due to hepatitis B virus Indian Journal of Medical Research 88: 111-117
Hou, Y-feng.; Yuan, S-tao.; Li, H-cheng.; Wu, J.; Lu, J-song.; Lu, L-juan.; Liu, G.; Shen, Z-zhou.; Ding, J.; Shao, Z-min. 2005: In vitro study of the effects of estrogen receptor beta expression on the biological behavior of a human breast cancer cell line Zhonghua Zhong Liu Za Zhi 27(7): 389-392
Steinfels, G.F.; Alberici, G.P.; Tam, S.W.; Cook, L. 1988: Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 1(4): 321-327
Mardesić, T.; Kosarová, M.; Zudová, D.; Jelínková, L.; Sobotka, V.; Gregor, V. 2011: Preimplantation genetic diagnosis (PGD) in carriers of chromosomal translocations: possibilities and results Ceska Gynekologie 76(2): 100-103
Primus, R.J.; Thurkauf, A.; Xu, J.; Yevich, E.; McInerney, S.; Shaw, K.; Tallman, J.F.; Gallagher, D.W. 1997: II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1 Journal of Pharmacology and Experimental Therapeutics 282(2): 1020-1027
Pola, V. 1970: Theoretical possibilities and the present status of laboratory diagnosis of hemophilic carriers. Review Vnitrni Lekarstvi 16(1): 61-68
Bischoff, E.D.; Gottardis, M.M.; Moon, T.E.; Heyman, R.A.; Lamph, W.W. 1998: Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma Cancer Research 58(3): 479-484
Corbett, G.E.; Finley, B.L.; Paustenbach, D.J.; Kerger, B.D. 1997: Systemic uptake of chromium in human volunteers following dermal contact with hexavalent chromium (22 mg/L) Journal of Exposure Analysis and Environmental Epidemiology 7(2): 179-189
Al-Tawil, N.G.; Marcusson, J.A.; Möller, E. 1983: Lymphocyte stimulation by trivalent and hexavalent chromium compounds in patients with chromium sensitivity. An aid to diagnosis Acta Dermato-Venereologica 63(4): 296-303